Introduction: The aim of this study was to investigate the effect of neoadjuvant chemoradiotherapy (nCRT) on perioperative outcomes in patients who underwent laparoscopic rectal cancer surgery.
Introduction
Laparoscopic colorectal surgery has been well accepted worldwide, offering similar oncological outcomes to open surgery, reduced analgesic requirement, early mobilization, and shorter hospitalization without additional complications. Neoadjuvant chemoradiotherapy (nCRT) followed by total mesorectal excision (TME) has become the standard treatment for locally advanced rectal cancer. [1, 2] nCRT has been shown to offer several advantages including improved local control, good tolerance, tumor downstaging, and complete pathological response (cPR. [3, 4] On the other hand, nCRT has been shown to be associated with increased perioperative complications and to present challenges for laparoscopic surgery due to a number of factors including increased operative time, radiation-induced edema, and fibrosis. [5, 6] In contrast, recent studies and meta-analyses have indicated that the nCRTinduced perioperative complications have been reduced with the increase in laparoscopic experience and nCRT has similar morbidity and mortality rates to those of open surgery in the laparoscopic treatment of rectal cancer. [1, 2, [7] [8] [9] [10] [11] [12] [13] [14] Additionally, the documentation of long-term oncological outcomes comparable to those of open surgery has eliminated concerns about the oncological outcomes of laparoscopic rectal cancer surgery. [8, 15] In the present study, we aimed to investigate the effect of nCRT on perioperative outcomes in patients undergoing laparoscopic rectal cancer surgery.
Materials and Methods
The retrospective study included patients that underwent laparoscopic surgery due to rectal adenocarcinoma in our clinic between January 1, 2017 and March 31, 2019. The study was approved by the local ethics committee. Patients with a rectal tumor at 15 cm from the anal verge, an endoscopic biopsy of rectal adenocarcinoma, and patients that underwent surgery under elective conditions and completed surgery with laparoscopy were included in the study. Patients with adjacent organ invasion (T4) and patients that underwent open surgery, additional resection due to metastasis, and transanal excision were excluded from the study. Each patient underwent oral and intravenous contrast-enhanced abdomino-pelvic and thoracic computed tomography (CT) and pelvic magnetic resonance imaging (MRI) for tumor staging. nCRT was performed in the patients that were detected with T3-T4 and/or lymph node metastasis on radiological examination. Long-term radiotherapy was performed with a total of 45-50. 4 Gy administered in 28 sessions, and the concurrent chemotherapy was performed with capecitabin. Curative surgery was performed 8-12 weeks after the completion of radiotherapy. The surgical procedure was administered by the same surgical team for all the patients. Sphincter-preserving resection (SPR) was performed with complete splenic flexure and left colon mobilization in a medial to lateral and superior to inferior fashion. TME was administered using the standard procedure. [16, 17] A standard pathologic examination was performed for all the resected specimens. Each specimen was evaluated for tumor differentiation, depth of tumor penetration, and lymph node metastases. Age, gender, body mass index (BMI), diverting ileostomy, operative time, American Society of Anesthesiologists (ASA) score, length of hospital stay, and postoperative course were recorded for each patient. Perioperative complications were classified according to the extended Clavien-Dindo classification. [18] The patients were divided into two groups as nCRT and non-nCRT.
Statistical Analysis
Data were analyzed using SPSS for Windows (IBM SPSS, Armonk, NY, USA). Descriptives were expressed as mean, standard deviation (SD), and percentages. Normal distribution of data was analyzed using Kolmogorov-Smirnov test. Parametric data were compared using Student's ttest and nonparametric data were compared using MannWhitney U test and Chi-square test. A p value of <0.05 was considered significant.
Results
A total of 77 patients underwent curative surgery due to rectal adenocarcinoma between January 1, 2017 and March 31, 2019. Of these, 16 patients were excluded from the study based on the exclusion criteria and thus 61 patients were included in the study (Fig. 1) . The 61 patients comprised 35 (57.4%) patients that received nCRT (nCRT group) and 26 (42.6%) patients that did not receive nCRT (p=0.606) ( Table 3 ). Mean length of hospital stay was 10.4±5.5 days in the nCRT group and 9±3.3 days in the nonnCRT group and no significant difference was established (p=0.199). No mortality occurred in any patient within the first 30 days after surgery.
Discussion
The results indicated that nCRT did not increase perioperative complications when administered prior to laparoscopic rectal cancer surgery. Moreover, based on the Clavien-Dindo classification, Grade III complications, which require invasive procedures, were detected in 3 and 1 patients in the nCRT and non-nCRT groups, respectively, and no significant difference was found between the two groups although the incidence was higher in the nCRT group compared to the non-nCRT group (p=0.606). Grade IV complications were detected in one patient in each group. In these patients, a stoma was created in the one patient in the nCRT group due to anastomotic leakage and the loop ileostomy was converted to an end ileostomy in the patient in the non-nCRT group due to fascial stenosis. Mean operative time was 298±36.8 min in the nCRT group and 243±50.2 min in the non-nCRT group and a significant difference was found (p<0.001). The longer operative time in the nCRT group could be attributed to the higher rate of ileostomy in this group. On the other hand, it is commonly known that radiation-induced complications such as inflammation, exudation, edema, and fibrosis present challenges for dissection, thereby leading to increased operative times and intraoperative blood loss. [13, 19] Based on randomized controlled trials demonstrating a significantly lower incidence of local relapse in patients receiving nCRT compared to adjuvant therapy, the National Comprehensive Cancer Network guidelines currently recommend nCRT for patients with stage II and III rectal cancer. Neoadjuvant radiation may offer several other advantages in comparison to adjuvant radiation such as increased sensitivity to radiation, reduced tumor volume allowing for a sphincter-preserving operation and less postoperative adhesions by avoiding radiationinduced injury to the surrounding small bowel. [3, 4, 9, 20, 21] On the other hand, laparoscopic rectal cancer surgery has recently emerged as a popular technique due to the advancements in medical technology and the increasing experience of surgeons. Moreover, its encouraging shortterm outcomes and the documentation of long-term oncological outcomes comparable to those of open surgery in randomized controlled studies and meta-analyses have eliminated concerns about the oncological outcomes of laparoscopic rectal cancer surgery. [2, 8, 15, [22] [23] [24] In a previous large series, Chapman et al. [9] evaluated patients that underwent surgery for rectal cancer and found no significant difference between the patients that underwent neoadjuvant chemoradiation followed by surgery and patients that underwent surgery alone with regard to overall 58 Laparosc Endosc Surg Sci morbidity and 30-day mortality. In a meta-analysis that mostly reviewed randomized controlled studies and compared open and laparoscopic surgery, Lu et al. [2] suggested that laparoscopy is a safe procedure to be administered after nCRT in patients with middle and lower rectal cancer.
Our study was limited since it had a retrospective design and a limited number of patients and had no long-term results. Moreover, no comparison was made between the patients that underwent open and laparoscopic surgery. Finally, the study presented findings from a single center and thus was not a multicenter study.
Conclusion
It was revealed that nCRT has no effect on perioperative complications despite leading to longer operative times in laparoscopic rectal cancer surgery. Accordingly, laparoscopic surgery can be safely performed following nCRT in patients with rectal cancer.
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